ICD-10 Coding for Porokeratosis(D49.2, D49.2B, D49.2N)
Learn about the ICD-10 codes for porokeratosis, including documentation requirements and coding tips for accurate medical billing.
Complete code families applicable to Porokeratosis
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| L56.5 | Disseminated Superficial Actinic Porokeratosis | Use for confirmed DSAP cases with histopathological evidence. |
|
| L85.2 | Keratosis punctata (palmaris et plantaris) | Use for non-actinic porokeratosis affecting palms or soles. |
|
| D49.2 | Neoplasm of uncertain behavior of skin | Use when porokeratosis shows potential for malignancy. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutPorokeratosis
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Porokeratosis.
Omitting lesion characteristics
Impact
Clinical: Inadequate clinical documentation., Regulatory: Potential non-compliance with coding standards., Financial: Risk of claim denials.
Mitigation
Ensure detailed lesion descriptions are included in notes., Verify biopsy results are documented if performed.
Using L57.0 for DSAP
Impact
Reimbursement: Claims may be denied if incorrect code is used., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data reporting.
Mitigation
Ensure cornoid lamella is confirmed before coding as DSAP.
Confusing plantar porokeratosis with calluses
Impact
Reimbursement: Incorrect coding may lead to denied claims., Compliance: Potential audit issues., Data Quality: Misleading clinical data.
Mitigation
Document specific lesion characteristics and confirm with histopathology if needed.
Inaccurate lesion coding
Impact
Coding lesions without confirming type can lead to audits.
Mitigation
Ensure biopsy confirmation and detailed documentation.